SpyGlass Pharma SGP
NASDAQ SGP
$26.16 +1.56 (+6.34%)
At close: Oct 20, 2026 · 4:00 PM EDT

SpyGlass Pharma (SGP) Operating Leases (2024 - 2026)

Updated

SpyGlass Pharma (SGP) recorded Operating Leases of $1.63 million in Q2 2026.

Analysis

SpyGlass Pharma (SGP) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, SpyGlass Pharma reported Operating Leases of $1.58 million, down 54.2% from FY2024.

  • Across earlier years, Operating Leases came in at $3.46 million in FY2024.
  • The Q2 2026 figure is the highest quarterly Operating Leases since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 SpyGlass Pharma 876.12 Mn 876.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.63 Mn
Dec 31, 2025 1.58 Mn
Dec 31, 2024 3.46 Mn
API Access

SpyGlass Pharma Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=SGP&period=max&api_key=YOUR_API_KEY